Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07885618

Factors Influencing Outcomes in ECMO and Impella Patients: Metabolic and Thyroid Hormone Dynamics

Conditions: Cardiogenic Shock, Euthyroid Sick Syndrome, Critical Illness

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 160
Sponsor: Gottsegen National Cardiovascular Institute

Location: Gottsegen Gyorgy National Cardiovascular Center Budapest

Summary

This prospective, single-center, consecutive observational study evaluates clinical, metabolic, and endocrine factors influencing survival and clinical outcomes in adult patients undergoing temporary mechanical circulatory support at the Cardiovascular Intensive Care Unit of Gottsegen Gyorgy National Cardiovascular Institute. While traditional cardiovascular risk factors in critically ill patients are well established, non-cardiovascular variables such as endocrine dysfunction, previous functional and nutritional status, metabolic parameters and clinical complications significantly impact short- and long-term outcomes. The study consecutively enrolls all eligible adult patients admitted to the intensive care unit requiring extracorporeal membrane oxygenation (ECMO) or Impella treatment. The primary objective is to evaluate 28-day and ICU mortality, while secondary objectives include characterizing cardiac and non-cardiac complications, nutritional status changes, and hormonal dysregulations.

Eligibility Criteria

Inclusion Criteria: * Adult patients (age ≥ 18 years) * Treatment with ECMO and/or Impella support * Informed consent provided by the patients next of kin/ legal representative Exclusion Criteria: * None

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07885618). StuddyBuddy aggregates publicly available trial information.